World Stem Cell Technology Market Will Generate $17.8bn in 2020

Wednesday 1 June 2016, Amsterdam

A new report, now available on ASDReports predicts the world stem cell technology market will generate $17.8bn in 2020, with rapid sales expansion to 2026. That forecast and others appear in Pharma Leader Series: Top Stem Cell Companies Report 2016-2026 – Market Analysis and Leading Players in the United States, Europe, Israel and Asia. That updated investigation analyses prospects for 25 leading stem cell companies worldwide.

The key player released that study in April 2016. That survey analyses events, prospects, clinical trials, R&D, market expansions and partnerships that shape the outlook for companies in the stem cells industry. It assesses leading companies – their strategies, expansions and acquisitions.

Mashael Zaidi, a healthcare industry analyst, said: “Stem cell technologies are on the verge of realising their therapeutic potential on the market. In this report we have profiled organisations with stem cell therapies in development, although a few have therapies on the market already. In order to realise the full market potential of these treatments, companies in this industry not only must advance their products to late stages of development and on to the market, but also must take into account pricing and regulatory concerns. Some companies have taken cost-effective measures in their manufacturing and technological processes as well as directed their efforts towards accelerated approval pathways in order to facilitate progress. However, even with these measures, regulations that optimally balance the advantages and risks of stem cell therapies are still some way away and more time is needed to provide regulatory guidance that can harness the full potential of the stem cells technologies market.”